DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.55
+0.15 (0.49%)
Apr 29, 2026, 1:30 PM CST

DIVA Laboratories Revenue

In the year 2025, DIVA Laboratories had annual revenue of 868.84M TWD with 0.76% growth. DIVA Laboratories had revenue of 229.72M in the quarter ending December 31, 2025, with 2.89% growth.

Revenue
868.84M
Revenue Growth
+0.76%
P/S Ratio
2.02
Revenue / Employee
5.74M
Employees
154
Market Cap
1.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025868.84M6.52M0.76%
Dec 31, 2024862.32M-31.52M-3.53%
Dec 31, 2023893.84M-55.36M-5.83%
Dec 31, 2022949.20M236.97M33.27%
Dec 31, 2021712.23M-24.69M-3.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Genetics Generation Advancement 603.11M
BIONET 1.24B
Kim Forest Enterprise 549.14M
Sofiva Genomics 385.71M
Puriblood Medical 117.35M
Pharmigene 149.25M
Welgene Biotech 375.94M
Revenue Rankings